Publication
Article Metrics
Citations
Online attention
Design of new disubstituted imidazo[1,2- b ]pyridazine derivatives as selective Haspin inhibitors. Synthesis, binding mode and anticancer biological evaluation
DOI:
10.1080/14756366.2020.1825408
Authors:
Jonathan
Elie
(Universite d’Orleans, UMR CNRS 7311)
,
Omid
Feizbakhsh
(Sorbonne Universite/CNRS UMR8227)
,
Nathalie
Desban
(Sorbonne Universite/CNRS UMR8227)
,
Béatrice
Josselin
(Sorbonne Universite/CNRS UMR8227; Sorbonne Universit e/CNRS FR242)
,
Blandine
Baratte
(Sorbonne Universite/CNRS UMR8227; Sorbonne Universit e/CNRS FR242)
,
Amandine
Bescond
(Sorbonne Universite/CNRS UMR8227)
,
Julien
Duez
(Sorbonne Universite/CNRS UMR8227)
,
Xavier
Fant
(Sorbonne Universite/CNRS UMR8227)
,
Stéphane
Bach
(Sorbonne Universite/CNRS UMR8227; Sorbonne Universite/CNRS FR242)
,
Dominique
Marie
(Sorbonne Universite/CNRS UMR714)
,
Matthieu
Place
(Universite d’Orleans, UMR CNRS 7311)
,
Sami
Ben Salah
(Universite d’Orleans, UMR CNRS 7311)
,
Agnes
Chartier
(Universite d’Orleans, UMR CNRS 7311)
,
Sabine
Berteina-raboin
(Universite d’Orleans, UMR CNRS 7311)
,
Apirat
Chaikuad
(Structure Genomics Consortium, Johann Wolfgang Goethe University)
,
Stefan
Knapp
(Structure Genomics Consortium, Johann Wolfgang Goethe University)
,
Fabrice
Carles
(Universite d’Orleans, UMR CNRS 7311)
,
Pascal
Bonnet
(Universite d’Orleans, UMR CNRS 7311)
,
Frédéric
Buron
(Universite d’Orleans, UMR CNRS 7311)
,
Sylvain
Routier
(Universite d’Orleans, UMR CNRS 7311)
,
Sandrine
Ruchaud
(Sorbonne Universite/CNRS UMR714)
Co-authored by industrial partner:
No
Type:
Journal Paper
Journal:
Journal Of Enzyme Inhibition And Medicinal Chemistry
, VOL 35
, PAGES 1840 - 1853
State:
Published (Approved)
Published:
January 2020
Diamond Proposal Number(s):
10619

Abstract: Haspin is a mitotic protein kinase required for proper cell division by modulating Aurora B kinase localisation and activity as well as histone phosphorylation. Here a series of imidazopyridazines based on the CHR-6494 and Structure Activity Relationship was established. An assessment of the inhibitory activity of the lead structures on human Haspin and several other protein kinases is presented. The lead structure was rapidly optimised using a combination of crystal structures and effective docking models, with the best inhibitors exhibiting potent inhibitory activity on Haspin with IC50 between 6 and 100 nM in vitro. The developed inhibitors displayed anti-proliferative properties against various human cancer cell lines in 2D and spheroid cultures and significantly inhibited the migration ability of osteosarcoma U-2 OS cells. Notably, we show that our lead compounds are powerful Haspin inhibitors in human cells, and did not block G2/M cell cycle transition due to improved selectivity against CDK1/CyclinB.
Journal Keywords: Imidazopyridazine; Haspin kinase; co-crystallisation and docking; cellular effects; 3D spheroids
Subject Areas:
Biology and Bio-materials,
Chemistry,
Medicine
Instruments:
I03-Macromolecular Crystallography